EMERYVILLE, Calif.,
Oct. 10, 2019 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leader in the development
and production of sustainable products for Health and Clean Beauty,
today announced the successful launch of its Pipette brand on
Amazon.com.
As of October 3, Pipette was
available at Pipettebaby.com, buybuyBABY.com, Amazon.com, and
Dermstore.com with very strong early results and significant
positive feedback from consumers. By month end, Pipette will be
available across all brick-and-mortar buybuyBaby stores nationwide
and available on Walmart.com by the end of November. Pipette
is expected to drive strong top-line sales performance for Amyris
in the fourth quarter and beyond.
To date, Pipette has received hundreds of consumer reviews with
96% of them rating the brand's products at 4 stars or better.
Customer testimonials:
"I'm happy I finally found the product that's 100% safe for my
daughter, clinically approved and clean. We loved it during our
bath and we'll come back and use it again."
"We have used it every night since we got it. Not only does it
leave his skin soft and smooth, it isn't super-thick and greasy
like Vaseline."
Amyris continues to deliver leading consumer brands powered by
the world leading synthetic biology platform. The company is
setting the standard for consumers with its No Compromise®
sustainable products. Our babies deserve great products on their
skin that are safe, natural, sustainably sourced, and at a price
that is accessible to all.
"Through the third quarter we have more than doubled product
revenue over the same period in 2018. We are on track for about
300% product revenue growth in the fourth quarter over the same
period last year," said John Melo,
Amyris President and CEO. "Our conservative approach in accounting
for new product scale up costs where we mostly capture capex and
non direct costs associated with scaling in our cost of goods sold
has resulted in an inflated cost of goods year to date, however,
our adjusted gross margin continues to be at the high end of our
stated 55-65% gross margin range. We have continued our strong
growth and gross margin performance beyond the second half of the
year and encourage those interested professional writers and
business analysts to prudently contact Amyris directly for
information. We are happy to share and clarify public
information."
Continued Melo, "We are delivering on our promise of doubling
recurring revenue or better year on year, maintaining our gross
margin between 55-65% and significantly reducing our EBITDA losses
by as much as half. The strong financial commitment of our leading
shareholders enables us to continue executing on our long-term
strategy and maintaining our investment in our technology advantage
and market leadership. We are managing our growth with strong
margins while remaining focused on having all of our existing
outstanding short-term debt, especially convertible debt, resolved
by year end and certainly as soon as possible. As the leading
synthetic biology company, we have a responsibility to make the
world healthier."
About Pipette
Pipette is a clean baby care brand with
a mission to give every child the best start. We serve parents who
strive to raise more conscious individuals while leaving behind a
better planet for their children. With the same passion that led
our scientists to ban over 2,000 potentially harmful ingredients
from our labs and products, we've made protecting babies our goal
by only using the safest, most necessary ingredients from the
purest sources. With the most stringent standards of testing and
safety, we create the highest quality clean formulations with
sustainable packaging. Because we believe that when we make it easy
for parents to take care of their little ones, we are taking care
of our future and our planet. Pipettebaby.com
About Amyris
Amyris is the integrated renewable
products company that is enabling the world's leading brands to
achieve sustainable growth. Amyris applies its innovative
bioscience solutions to convert plant sugars into hydrocarbon
molecules and produce specialty ingredients and consumer products.
The company is delivering its No Compromise® products and services
across a number of markets, including specialty and performance
chemicals, flavors and fragrances, cosmetics ingredients,
pharmaceuticals, and nutraceuticals. More information about the
company is available at www.amyris.com.
Forward-Looking Statements
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding future events, such as the
anticipated availability of Pipette products, expected Pipette
sales performance, anticipated Amyris product revenue and product
revenue growth, expected Amyris gross margin and EBITDA, and the
anticipated resolution of Amyris's outstanding short-term debt.
These statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties, including risks related to Amyris's liquidity
and ability to fund operating and capital expenses, risks related
to potential delays or failures in development, production and
commercialization of products, risks related to Amyris's reliance
on third parties, and other risks detailed from time to time in
filings Amyris makes with the Securities and Exchange Commission,
including Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K. Amyris disclaims any
obligation to update information contained in these forward-looking
statements, whether as a result of new information, future events,
or otherwise.
Amyris, the Amyris logo, No Compromise, and Pipette are
trademarks or registered trademarks of Amyris, Inc. in the U.S.
and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-pipette-brand-successfully-launches-on-amazoncom-300936230.html
SOURCE Amyris, Inc.